Huahui Health

Industry · 14 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infect Chronic Hepatitis B Virus Infection	Phase 2	2026-04-29
Not Yet Recruiting	A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection Chronic Hepatitis D Infection	Phase 3	2026-03-25
Completed	A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients Chronic Hepatitis B Virus Infection	Phase 1	2024-12-20
Completed	A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infec Chronic Hepatitis Delta Virus Infection	Phase 2	2023-06-16
Enrolling By Invitation	HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2 COVID-19	Phase 3	2023-03-31
Completed	A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19 COVID-19	Phase 2	2023-01-18
Completed	A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers COVID-19	Phase 1	2022-11-08
Completed	A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Chronic HBV Infection	Phase 2	2022-07-20
Completed	A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers Hepatitis B	Phase 1	2022-05-03
Completed	A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19 COVID-19	Phase 1	2022-04-16
Completed	A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy Volunteer COVID-19 Respiratory Infection	Phase 1	2021-11-01
Completed	A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chro Chronic Hepatitis B	Phase 2	2021-10-09
Terminated	A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B Chronic Hepatitis B and Hepatitis D Co-infection	Phase 2	2021-08-11
Completed	A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Viru Chronic HBV Infection	Phase 1	2019-08-05